Millipore Sigma Vibrant Logo

481981 Nifedipine - CAS 21829-25-4 - Calbiochem

Relatively selective blocker of L-type Ca2+ channels.

Nifedipine - CAS 21829-25-4 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: L-Type Calcium Channel Blocker III

Primary Target: L-type Ca2+ channels
View Products on Sigmaaldrich.com
481981
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

CAS #Empirical Formula
21829-25-4C₁₇H₁₈N₂O₆

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
481981-250MG
Retrieving availability...
—
Limited Availability Limited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Plastic ampoule 250 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewRelatively selective blocker of L-type Ca2+ channels. One of the most extensively studied blockers of 1,4-dihydropyridine-type Ca2+ channels, and a pharmacologically-useful vasodilator. Induces apoptosis in human glioblastoma cells.
      Catalogue Number481981
      Brand Family Calbiochem®
      SynonymsL-Type Calcium Channel Blocker III
      References
      ReferencesReid, K., et al. 1997. J. Pharmacol. Exp. Ther. 283, 993.
      Kondo, S., et al. 1995. J. Neurosurg. 82, 469.
      Antkiewicz-Michaluk, L., et al. 1994. Eur. J. Pharmacol. 254, 9.
      Calabresi, P., et al. 1994. J. Neurosci. 14, 4871.
      Akman, M.S., et al. 1993. Endocrinology 132, 1286.
      Cirillo, M., et al. 1993. Circ. Res. 72, 847.
      Young, R.J., et al. 1993. Biochim. Biophys. Acta 1146, 81.
      Janis, R., et al. 1987. Adv. Drug Res. 16, 311.
      Product Information
      CAS number21829-25-4
      ATP CompetitiveN
      FormYellow solid
      Hill FormulaC₁₇H₁₈N₂O₆
      Chemical formulaC₁₇H₁₈N₂O₆
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetL-type Ca2+ channels
      Purity≥98% by UV
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSUS7975000
      Safety Information
      R PhraseR: 22

      Harmful if swallowed.
      S PhraseS: 36-26

      Wear suitable protective clothing.
      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful & Carcinogenic / Teratogenic
      Storage +15°C to +30°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalog Number GTIN
      481981-250MG 04055977183443

      Documentation

      Nifedipine - CAS 21829-25-4 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Nifedipine - CAS 21829-25-4 - Calbiochem Certificates of Analysis

      TitleLot Number
      481981

      References

      Reference overview
      Reid, K., et al. 1997. J. Pharmacol. Exp. Ther. 283, 993.
      Kondo, S., et al. 1995. J. Neurosurg. 82, 469.
      Antkiewicz-Michaluk, L., et al. 1994. Eur. J. Pharmacol. 254, 9.
      Calabresi, P., et al. 1994. J. Neurosci. 14, 4871.
      Akman, M.S., et al. 1993. Endocrinology 132, 1286.
      Cirillo, M., et al. 1993. Circ. Res. 72, 847.
      Young, R.J., et al. 1993. Biochim. Biophys. Acta 1146, 81.
      Janis, R., et al. 1987. Adv. Drug Res. 16, 311.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-May-2008 RFH
      SynonymsL-Type Calcium Channel Blocker III
      DescriptionRelatively selective blocker of L-type Ca2+ channels. One of the most extensively studied Ca2+ channel blockers of 1,4-dihydropyridine-type and a pharmacologically useful vasodilator. Induces apoptosis in human glioblastoma cells.
      FormYellow solid
      CAS number21829-25-4
      RTECSUS7975000
      Chemical formulaC₁₇H₁₈N₂O₆
      Structure formulaStructure formula
      Purity≥98% by UV
      SolubilityDMSO or Ethanol
      Storage Protect from light
      +15°C to +30°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful & Carcinogenic / Teratogenic
      Merck USA index14, 6528
      ReferencesReid, K., et al. 1997. J. Pharmacol. Exp. Ther. 283, 993.
      Kondo, S., et al. 1995. J. Neurosurg. 82, 469.
      Antkiewicz-Michaluk, L., et al. 1994. Eur. J. Pharmacol. 254, 9.
      Calabresi, P., et al. 1994. J. Neurosci. 14, 4871.
      Akman, M.S., et al. 1993. Endocrinology 132, 1286.
      Cirillo, M., et al. 1993. Circ. Res. 72, 847.
      Young, R.J., et al. 1993. Biochim. Biophys. Acta 1146, 81.
      Janis, R., et al. 1987. Adv. Drug Res. 16, 311.